| KYDVRIXO GlaxoSmithKline Biologicals SA
98294704 01 Dec 2023 | on 17 Dec 2024
| Vaccines; Anti-infectives; Pharmaceutical preparations and substances ... Class 005 Class 005 Pharmaceutical Products Vaccines; Anti-infectives; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders | | | MENPENVIQ GlaxoSmithKline Biologicals SA
97251143 02 Feb 2022 | on 17 Dec 2024
| Pharmaceutical preparations for the treatment of infectious diseases, ... Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Vaccines | | | VARZYVAL GlaxoSmithKline Biologicals SA
98294725 01 Dec 2023 | on 17 Dec 2024
| Vaccines; Anti-infectives; Pharmaceutical preparations and substances ... Class 005 Class 005 Pharmaceutical Products Vaccines; Anti-infectives; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders | | | KYDRIXVO GlaxoSmithKline Biologicals SA
98294690 01 Dec 2023 | on 17 Dec 2024
| Vaccines; Anti-infectives; Pharmaceutical preparations and substances ... Class 005 Class 005 Pharmaceutical Products Vaccines; Anti-infectives; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders | | | VIMMRYXTO GlaxoSmithKline Biologicals SA
98294740 01 Dec 2023 | on 17 Dec 2024
| Vaccines; Anti-infectives; Pharmaceutical preparations and substances ... Class 005 Class 005 Pharmaceutical Products Vaccines; Anti-infectives; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders | | | VORIXTO GlaxoSmithKline Biologicals SA
98294754 01 Dec 2023 | on 17 Dec 2024
| Vaccines; Anti-infectives; Pharmaceutical preparations and substances ... Class 005 Class 005 Pharmaceutical Products Vaccines; Anti-infectives; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders | | | VYZEEVEI GlaxoSmithKline Biologicals SA
98294776 01 Dec 2023 | on 17 Dec 2024
| Vaccines; Anti-infectives; Pharmaceutical preparations and substances ... Class 005 Class 005 Pharmaceutical Products Vaccines; Anti-infectives; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders | | | ROMENVI GlaxoSmithKline Biologicals SA
97251122 02 Feb 2022 | on 17 Dec 2024
| Pharmaceutical preparations for the treatment of infectious diseases, ... Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Vaccines | | | VYRIXKYD GlaxoSmithKline Biologicals SA
98294761 01 Dec 2023 | on 17 Dec 2024
| Vaccines; Anti-infectives; Pharmaceutical preparations and substances ... Class 005 Class 005 Pharmaceutical Products Vaccines; Anti-infectives; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders | | | VIMMRIXEQ GlaxoSmithKline Biologicals SA
98294735 01 Dec 2023 | on 17 Dec 2024
| Vaccines; Anti-infectives; Pharmaceutical preparations and substances ... Class 005 Class 005 Pharmaceutical Products Vaccines; Anti-infectives; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders | | 
